skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Biological And Medical Sciences remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study
Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study

Le Treut, J. ; Sault, M.C. ; Lena, H. ; Souquet, P.J. ; Vergnenegre, A. ; Le Caer, H. ; Berard, H. ; Boffa, S. ; Monnet, I. ; Damotte, D. ; Chouaid, C.

Annals of oncology, 2013-06, Vol.24 (6), p.1548-1552 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer : JCOG 9702
Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer : JCOG 9702
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer : JCOG 9702

OKAMOTO, H ; WATANABE, K ; KUNIKANE, H ; YOKOYAMA, A ; KUDOH, S ; ASAKAWA, T ; SHIBATA, T ; KUNITOH, H ; TAMURA, T ; SAIJO, N

British journal of cancer, 2007-07, Vol.97 (2), p.162-169 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
Material Type:
Artigo 		Adicionar ao Meu Espaço

Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide

Wu, Chyuan-Chuan ; Li, Tsai-Kun ; Farh, Lynn ; Lin, Li-Ying ; Lin, Te-Sheng ; Yu, Yu-Jen ; Yen, Tien-Jui ; Chiang, Chia-Wang ; Chan, Nei-Li

Science (American Association for the Advancement of Science), 2011-07, Vol.333 (6041), p.459-462 [Periódico revisado por pares]

Washington, DC: American Association for the Advancement of Science

Texto completo disponível

Citações Citado por
4
Simultaneous determination of etoposide and a piperine analogue (PA-1) by UPLC–qTOF-MS: Evidence that PA-1 enhances the oral bioavailability of etoposide in mice
Simultaneous determination of etoposide and a piperine analogue (PA-1) by UPLC–qTOF-MS: Evidence that PA-1 enhances the oral bioavailability of etoposide in mice
Material Type:
Artigo 		Adicionar ao Meu Espaço

Simultaneous determination of etoposide and a piperine analogue (PA-1) by UPLC–qTOF-MS: Evidence that PA-1 enhances the oral bioavailability of etoposide in mice

Sachin, B.S. ; Najar, I.A. ; Sharma, S.C. ; Verma, M.K. ; Reddy, M.V. ; Anand, R. ; Khajuria, R.K. ; Koul, S. ; Johri, R.K.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2010-03, Vol.878 (9), p.823-830 [Periódico revisado por pares]

Amsterdam: Elsevier B.V

Texto completo disponível

Citações Citado por
5
Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial
Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial

HERMES, Andreas ; BERGMAN, Bengt ; SORENSON, Sverre ; BREMNES, Roy ; EK, Lars ; FLUGE, Sverre ; SEDERHOLM, Christer ; SUNDSTRØM, Stein ; THANING, Lars ; VILSVIK, Jan ; AASEBØ, Ulf

Journal of clinical oncology, 2008-09, Vol.26 (26), p.4261-4267 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
A German multicenter, randomized phase III trial comparing irinotecan–carboplatin with etoposide–carboplatin as first-line therapy for extensive-disease small-cell lung cancer
A German multicenter, randomized phase III trial comparing irinotecan–carboplatin with etoposide–carboplatin as first-line therapy for extensive-disease small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A German multicenter, randomized phase III trial comparing irinotecan–carboplatin with etoposide–carboplatin as first-line therapy for extensive-disease small-cell lung cancer

Schmittel, A. ; Sebastian, M. ; Fischer von Weikersthal, L. ; Martus, P. ; Gauler, T.C. ; Kaufmann, C. ; Hortig, P. ; Fischer, J.R. ; Link, H. ; Binder, D. ; Fischer, B. ; Caca, K. ; Eberhardt, W.E.E. ; Keilholz, U.

Annals of oncology, 2011-08, Vol.22 (8), p.1798-1804 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first‐relapse/primary refractory diffuse large B‐cell lymphoma
Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first‐relapse/primary refractory diffuse large B‐cell lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first‐relapse/primary refractory diffuse large B‐cell lymphoma

Feldman, Tatyana ; Mato, Anthony R. ; Chow, Kar F. ; Protomastro, Ewelina A. ; Yannotti, Kara M. L. ; Bhattacharyya, Pritish ; Yang, Xiao ; Donato, Michele L. ; Rowley, Scott D. ; Carini, Carolanne ; Valentinetti, Marisa ; Smith, Judith ; Gadaleta, Gabriella ; Bejot, Coleen ; Stives, Susan ; Timberg, Mary ; Kdiry, Sabrina ; Pecora, Andrew L. ; Beaven, Anne W. ; Goy, Andre

British journal of haematology, 2014-07, Vol.166 (1), p.77-83 [Periódico revisado por pares]

Oxford: Blackwell

Texto completo disponível

Citações Citado por
8
A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer
A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer

Mavroudis, D. ; Papadakis, E. ; Veslemes, M. ; Tsiafaki, X. ; Stavrakakis, J. ; Kouroussis, C. ; Kakolyris, S. ; Bania, E. ; Jordanoglou, J. ; Agelidou, M. ; Vlachonicolis, J.

Annals of oncology, 2001-04, Vol.12 (4), p.463-470 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
9
Phase 2 Trial of Combined Cisplatin, Etoposide, Gemcitabine, and Methylprednisolone (PEGS) in Peripheral T-Cell Non-Hodgkin Lymphoma: Southwest Oncology Group Study S0350
Phase 2 Trial of Combined Cisplatin, Etoposide, Gemcitabine, and Methylprednisolone (PEGS) in Peripheral T-Cell Non-Hodgkin Lymphoma: Southwest Oncology Group Study S0350
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 2 Trial of Combined Cisplatin, Etoposide, Gemcitabine, and Methylprednisolone (PEGS) in Peripheral T-Cell Non-Hodgkin Lymphoma: Southwest Oncology Group Study S0350

MAHADEVAN, Daruka ; UNGER, Joseph M ; SPIER, Catherine M ; PERSKY, Daniel O ; YOUNG, Fay ; LEBLANC, Michael ; FISHER, Richard I ; MILLER, Thomas P

Cancer, 2013-01, Vol.119 (2), p.371-379 [Periódico revisado por pares]

Hoboken, NJ: Wiley-Blackwell

Texto completo disponível

Citações Citado por
10
E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer
E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer

Owonikoko, Taofeek K. ; Aisner, Joseph ; Wang, Xin Victoria ; Dahlberg, Suzanne E. ; Rubin, Eric H. ; Ramalingam, Suresh S. ; Gounder, Murugesan ; Rausch, Paul Gregory ; Axelrod, Rita S. ; Schiller, Joan H.

Cancer chemotherapy and pharmacology, 2014-01, Vol.73 (1), p.171-180 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (18.713)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (19.332)
  2. Anais de Congresso  (10)
  3. magazinearticle  (1)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1988  (385)
  2. 1988Até1993  (1.537)
  3. 1994Até1999  (3.894)
  4. 2000Até2006  (7.051)
  5. Após 2006  (6.477)
  6. Mais opções open sub menu

Idioma 

  1. Japonês  (3.510)
  2. Alemão  (11)
  3. Português  (2)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.